Read: How Pharma Supply Chain Leaders are Mitigating Rising Security Risks with Visibility Technology
Pharmaceutical supply chains are growing more complex due to globalization, digitalization, and the increased movement of highly temperature-sensitive products and therapies. While these changes drive innovation, they also increase risks such as cyberattacks, theft, and product tampering.
A December 2024 survey by Tive and BioPharma Dive explored pharma supply chain leaders’ deepening concerns about the rising threats to supply chain security, as well as the security strategies and technologies being introduced to address them.
Key Findings:
Respondents identified a lack of real-time visibility into shipments as a major vulnerability, contributing to issues like compromised cold chain integrity and product theft. To counter these risks, many companies are adopting visibility technologies that provide real-time insights, helping them prevent incidents, improve operational efficiency, and ensure secure, on-time deliveries.
Key Takeaways:
- Rising Risks in Pharma Supply Chains: 68% of executives are deeply concerned about increasing theft, fraud, and cyberattacks, with inadequate real-time visibility identified as a critical vulnerability.
- Impact of Visibility Technology: Over 83% of companies are leveraging real-time tracking and condition monitoring to reduce security incidents, improve operational efficiency, and ensure cold chain integrity.
- Future-Proofing with Insights: Advanced visibility tools enable independent data verification, proactive risk mitigation, and enhanced collaboration with trusted partners to strengthen the entire supply chain ecosystem.